These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27130164)

  • 1. Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol.
    Schünemann HJ; Ventresca M; Crowther M; Briel M; Zhou Q; Garcia D; Lyman G; Noble S; Macbeth F; Griffiths G; DiNisio M; Iorio A; Beyene J; Mbuagbaw L; Neumann I; Van Es N; Brouwers M; Brozek J; Guyatt G; Levine M; Moll S; Santesso N; Streiff M; Baldeh T; Florez I; Gurunlu Alma O; Solh Z; Ageno W; Marcucci M; Bozas G; Zulian G; Maraveyas A; Lebeau B; Buller H; Evans J; McBane R; Bleker S; Pelzer U; Akl EA;
    BMJ Open; 2016 Apr; 6(4):e010569. PubMed ID: 27130164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis.
    Schünemann HJ; Ventresca M; Crowther M; Briel M; Zhou Q; Noble S; Macbeth F; Griffiths G; Garcia D; Lyman GH; Di Nisio M; Iorio A; Mbuagbaw L; Neumann I; van Es N; Brouwers M; Guyatt G; Streiff MB; Marcucci M; Baldeh T; Florez ID; Alma OG; Solh Z; Bossuyt PM; Kahale LA; Ageno W; Bozas G; Büller HR; Lebeau B; Lecumberri R; Loprinzi C; McBane R; Sideras K; Maraveyas A; Pelzer U; Perry J; Klerk C; Agnelli G; Akl EA
    Lancet Haematol; 2020 Oct; 7(10):e746-e755. PubMed ID: 32976752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral anticoagulation in ambulatory patients with cancer.
    Akl EA; Kahale LA; Hakoum MB; Matar CF; Sperati F; Barba M; Yosuico VED; Terrenato I; Synnot A; Schünemann H
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006652. PubMed ID: 28892556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral anticoagulation in ambulatory patients with cancer.
    Akl EA; Kahale LA; Ballout RA; Barba M; Yosuico VE; van Doormaal FF; Middeldorp S; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2014 Dec; (12):CD006652. PubMed ID: 25491949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
    Marcucci M; Etxeandia-Ikobaltzeta I; Yang S; Germini F; Gupta S; Agarwal A; Ventresca M; Tang S; Morgano GP; Wang M; Ahmed MM; Neumann I; Izcovich A; Criniti J; Popoff F; Devereaux PJ; Dahm P; Anderson D; Lavikainen LI; Tikkinen KAO; Guyatt GH; Schünemann HJ; Violette PD
    BMJ; 2022 Mar; 376():e066785. PubMed ID: 35264372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006652. PubMed ID: 21491396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis.
    Eck RJ; Elling T; Sutton AJ; Wetterslev J; Gluud C; van der Horst ICC; Gans ROB; Meijer K; Keus F
    BMJ; 2022 Jul; 378():e070022. PubMed ID: 35788047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006652. PubMed ID: 21249680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Zorzela LM; Perini E
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007557. PubMed ID: 28431186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Jones LE
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation.
    Akl EA; van Doormaal FF; Barba M; Kamath G; Kim SY; Kuipers S; Middeldorp S; Yosuico V; Dickinson HO; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006652. PubMed ID: 17636846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006466. PubMed ID: 34622445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.